Kenya reports second Ebola death as DR Congo vaccine trial begins

· Health · Kenya · DR Congo

Kenya's Health Ministry announced the country's second Ebola death on Friday, a 65-year-old woman who was a close relative of the first patient and who developed symptoms while in quarantine. The news came as the first clinical trial of an Ebola vaccine began in the Democratic Republic of Congo, which is battling an outbreak, according to the head of the World Health Organization. Ebola is a viral hemorrhagic fever with high fatality rates, and rapid ring vaccination and contact tracing are the main tools for containment. Kenya's case is tied to a known transmission chain rather than an unknown source, but a second death within a family cluster raises the stakes for regional surveillance. The Congo trial could provide evidence on vaccine protection during an active outbreak.

Why it matters：Two Ebola deaths in Kenya plus a trial launched mid-outbreak underline how quickly the virus crosses borders and how central real-time vaccine evidence is to containment.

Key points

  • The Kenyan patient, 65, was a close relative of the first patient and died after symptoms appeared in quarantine.
  • The WHO director-general said the first Ebola vaccine clinical trial in DR Congo began Friday.
  • Kenya's second case is linked to a known transmission chain rather than an unidentified source.

Sources (original reporting)

More stories from this day